Belimumab in Autoimmune Hepatitis
NCT06381453
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Hepatitis
Interventions
DRUG:
Belimumab Auto-Injector [Benlysta]
Sponsor
University Health Network, Toronto
Collaborators
[object Object]